Home / Biotechnology / Point-Of-Care Diagnostics / Testing (POCT) Market By Product (Glucose Monitoring, Cardiac Markers, Infectious Diseases Testing, Cholesterol Testing, Coagulation Monitoring, Pregnancy And Fertility Testing, Hematology Testing, Blood Gas Testing), By End-User (Clinics, Home, Laboratories, Assisted Living Healthcare Facilities, Hospitals) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Point-Of-Care Diagnostics / Testing (POCT) Market By Product (Glucose Monitoring, Cardiac Markers, Infectious Diseases Testing, Cholesterol Testing, Coagulation Monitoring, Pregnancy And Fertility Testing, Hematology Testing, Blood Gas Testing), By End-User (Clinics, Home, Laboratories, Assisted Living Healthcare Facilities, Hospitals) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022

Published: Apr 2016 | Report Code: 57804-04-16

This report on point-of-care diagnostics / testing (POCT) market studies various products and end-users market. POCT is considered as one of the most affordable technologies of global diagnostics market, and development in POCT technologies over period of time has been carried out through innovations in smart and portable bio-sensor, computing, and information and communication technologies. According to market experts the factors assisting the growth of POC diagnostics market are several government initiatives have aided in the development of innovative outpatient care models, to minimize hospital stays and rapidly increasing demand for home healthcare globally.

For the purpose of this study, the global point of care diagnostics market on the basis of product type is segmented into glucose monitoring,  urinalysis testing, cardiac markers , infectious diseases testing,  cholesterol testing, coagulation monitoring , pregnancy and fertility testing, hematology testing, fecal occult testing kits, blood gas testing, cancer markers, drugs of abuse testing, and others . Market size estimates and forecast for these segments for the period 2013 to 2022 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2022, considering 2015 as the base year.

On the basis of end users point of care diagnostic market is segmented as clinics, home, laboratories, assisted living healthcare facilities and hospitals. The diagnostic tests performed on a large scale in these healthcare institutes and increasing demand for further expansion of point of care diagnostic facilities are the key factors fueling the growth of point of care diagnostics market in hospitals and clinics. Market size estimates and forecast for these segments for the period 2013 to 2022 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2022, considering 2015 as the base year.

The POC diagnostics and testing market has been geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, and GCC countries. Market size and forecast for these segments during 2013 to 2022 and their CAGRs for the period 2016 to 2022 are provided in this report.

The key manufacturers from point of care diagnostics market are carrying out constant efforts and huge investments on research and development of innovative products which are enabled with advanced technologies. The major key players profiled in the POC diagnostics and testing market are on the basis of various characteristics such as business description, financial health and budget allocation, product portfolio, and news coverage. The key players profiled in this report are Roche Diagnostics Ltd., Alere Inc., Siemens AG, and Beckman Coulter, Inc., Johnson & Johnson, Bayer AG, and Abbott Laboratories, Abaxis, Inc., Becton, Dickinson And Company, and Nipro Diagnostics, Inc.

Chapter 1 Preface
1.1 Report Description
1.1.1 Study Purpose
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Point-of-Care Diagnostics/Testing Market, by Product Type, 2015 (USD Mn)
2.2 Point-of-Care Diagnostics/Testing Market Share, by End Users, 2015 & 2022 (Value %)
2.3 Point-of-Care Diagnostics/Testing Market Share, by Geography, 2015 (Value %)

Chapter 3 Global Point-of-Care Diagnostics/Testing Market: Market Dynamics and Outlook
3.1 Point-of-Care Diagnostics/Testing : Current and Future Trends
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.6 Market Share Analysis: Key Point-of-Care Diagnostics/Testing Manufacturers, 2015 (%)

Chapter 4 Global Point-of-Care Diagnostics/Testing Market Analysis, by Product Type
4.1 Preface
4.2 Glucose Monitoring
4.3 Cardiac Markers
4.4 Infectious Diseases Testing
4.5 Cholesterol Testing
4.6 Coagulation Monitoring
4.7 Pregnancy And Fertility Testing
4.8 Hematology Testing
4.9 Blood Gas Testing
4.10 Others

Chapter 5 Global Point-of-Care Diagnostics/Testing Market Analysis, by End-User
5.1 Preface
5.2 Clinics
5.3 Home
5.4 Laboratories
5.5 Assisted living healthcare facilities
5.6 Hospitals

Chapter 6 Global Point-of-Care Diagnostics/Testing Market, by Geography
6.1 Preface
6.2 North America
6.2.1 U.S
6.2.2 Canada
6.3 Europe
6.3.1 U.K
6.3.2 Germany
6.3.3 Rest of Europe
6.4 Asia Pacific
6.4.1 China
6.4.2 Japan
6.4.3 Rest of Asia Pacific
6.5 Latin America (LATAM)
6.5.1 Brazil
6.5.2 Mexico
6.5.3 Rest of LATAM
6.6 Middle East and Africa (MEA)

Chapter 7 Future Growth Advocacies

Chapter 8 Company Profiles
8.1 Abbott Laboratories, Inc.
8.1.1 Business Description
8.1.2 Financial Health and budget allocation
8.1.3 Product Positions/Portfolio
8.1.4 Key Competitors
8.1.5 News Coverage
8.2 Abaxis, Inc.
8.2.1 Business Description
8.2.2 Financial Health and Budget Allocation
8.2.3 Product Positions/Portfolio
8.2.4 Key Competitors
8.2.5 News Coverage
8.3 Alere, Inc.
8.3.1 Business Description
8.3.2 Financial Health and Budget Allocation
8.3.3 Product Positions/Portfolio
8.3.4 Key Competitors
8.3.5 News Coverage
8.4 Bayer AG
8.4.1 Business Description
8.4.2 Financial Health and budget allocation
8.4.3 Product Positions/
8.4.4 Key Competitors
8.4.5 News Coverage
8.5 Danaher Corporation
8.5.1 Business Description
8.5.2 Financial Health and budget allocation
8.5.3 Product Positions/Portfolio
8.5.4 Key Competitors
8.5.5 News Coverage
8.6 Becton, Dickinson And Company
8.6.1 Business Description
8.6.2 Financial Health and budget allocation
8.6.3 Product Positions/Portfolio
8.6.4 Key Competitors
8.6.5 News Coverage
8.7 Johnson & Johnson
8.7.1 Business Description
8.7.2 Financial Health and budget allocation
8.7.3 Product Positions/Portfolio
8.7.4 Key Competitors
8.7.5 News Coverage
8.8 Nipro Corporation
8.8.1 Business Description
8.8.2 Financial Health and budget allocation
8.8.3 Product Positions/Portfolio
8.8.4 Key Competitors
8.8.5 News Coverage
8.9 Roche Diagnostics Limited
8.9.1 Business Description
8.9.2 Financial Health and budget allocation
8.9.3 Product Positions/Portfolio
8.9.4 Key Competitors
8.9.5 News Coverage
8.10 Siemens Healthcare
8.10.1 Business Description
8.10.2 Financial Health and budget allocation
8.10.3 Product Positions/Portfolio
8.10.4 Key Competitors
8.4.5 News Coverage
8.11 Samsung Medison Co. Ltd.
8.11.1 Business Description
8.11.2 Financial Health and budget allocation
8.11.3 Product Positions/Portfolio
8.11.4 Key Competitors
8.11.5 News Coverage

List of Figures

FIG. 1 Point-of-Care Diagnostics / Testing : Market Segmentation
FIG. 2 Point-of-Care Diagnostics / Testing Market, by Product Type, 2015 (USD Mn)
FIG. 3 Point-of-Care Diagnostics / Testing Market Share, by End-Users, 2015 & 2022 (Value %)
FIG. 4 Point-of-Care Diagnostics / Testing Market Share, by Geography, 2015 (Value %)
FIG. 5 Attractive Investment Proposition, Point-of-Care Diagnostics / Testing Market, 2015
FIG. 6 Key Players Market Share Analysis for Point-of-Care Diagnostics / Testing, 2015(%)
FIG. 7 Global Glucose Monitoring Products Market Revenue, 2013 – 2022 (USD Mn)
FIG. 8 Global Cardiac MarkerProducts Market Revenue, 2013 – 2022 (USD Mn)
FIG. 9 Global Infectious Diseases Testing Products Market Revenue, 2013 – 2022 (USD
Mn)
FIG. 10 Global Cholesterol Testing Products Market Revenue, 2013 – 2022 (USD Mn)
FIG. 11 Global Coagulation Monitoring Products Market Revenue, 2013 – 2022 (USD Mn)
FIG. 12 Global Pregnancy and Fertility Testing Products Market Revenue, 2013 – 2022 (USD Mn)
FIG. 13 Global Hematology Testing Products Market Revenue, 2013 – 2022 (USD Mn)
FIG. 14 Global Blood Gas Testing Products Market Revenue, 2013 – 2022 (USD Mn)
FIG. 15 Global Other Products Market Revenue, 2013 – 2022 (USD Mn)
FIG. 16 Global Clinics in Point-of-Care Diagnostics/Testing Market Revenue, 2013 – 2022
(USD Mn)
FIG. 17 Global Home in Point-of-Care Diagnostics/Testing Market Revenue, 2013 – 2022 (USD
Mn)
FIG. 18 Global Laboratories in Point-of-Care Diagnostics/Testing Market Revenue, 2013 – 2022
(USD Mn)
FIG. 19 Global Assisted living healthcare facilities in Point-of-Care Diagnostics/Testing Market
Revenue, 2013 – 2022 (USD Mn)
FIG. 20 Global Hospitals in Point-of-Care Diagnostics/Testing Market Revenue, 2013 – 2022 (USD
Mn)  

List of Tables

TABLE 1 Global Point-of-Care Diagnostics/Testing Market Revenue, by Product Type, 2013 – 2022 (USD Mn)
TABLE 2 Global Point-of-Care Diagnostics/Testing Market Revenue, by Technology, 2013 – 2022 (USD Mn)
TABLE 3 Global Point-of-Care Diagnostics/Testing Market Revenue, by Geography, 2013 – 2022 (USD Mn)
TABLE 4 North America Point-of-Care Diagnostics/Testing Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 5 Europe Point-of-Care Diagnostics/Testing Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 6 Asia - Pacific Point-of-Care Diagnostics/Testing Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 7 Latin America Point-of-Care Diagnostics/Testing Market Revenue, by Country, 2013 – 2022 (USD Mn)
TABLE 8 Middle East and Africa Point-of-Care Diagnostics/Testing Market Revenue, by Region, 2013 – 2022 (USD Mn)

Based on the type of products, the global point-of-care diagnostics / testing (POCT) market is segmented as follows:

  • Glucose Monitoring
  • Cardiac Markers
  • Infectious Diseases Testing
  • Cholesterol Testing
  • Coagulation Monitoring
  • Pregnancy And Fertility Testing
  • Hematology Testing
  • Blood Gas Testing
  • Others (Fecal Occult Testing, Cancer Markers, Urinalysis Testing, Drugs Of Abuse Testing, etc.)

In year 2015, the glucose monitoring segment accounted for the largest market share in the POCT market. The incidences and prevalence of diabetes and the requirement of regular measurement of sugar levels in the blood are the key factors driving the point of care glucose monitoring market. According to International Diabetes Federation (IDF), the number of people living with the disease is expected to soar to 552 million by 2030 -- equating to three new cases every 10 seconds -- up from 366 million in 2011. However, the rapid diagnostics market and OTC is expected to show lucrative growth over the forecast period owing to the rising demand for early disease diagnosis and self-diagnosis to instigate immediate and on-time treatment of chronic diseases.

Point-Of-Care Diagnostics / Testing (POCT) Market

Based on the end-users, the point-of-care diagnostics / testing (POCT) market is segmented into:

  • Clinics
  • Home
  • Laboratories
  • Assisted living healthcare facilities
  • Hospitals

In base year 2015, the clinics and hospitals collectively attribute the largest share in the market in terms of revenue. The diagnostic tests are carried out on a large scale in these healthcare institutes and rising demand for accessible and patient compliant diagnostics technologies are the key factors fueling the growth of POC diagnostics market in hospitals and clinics. Moreover, the aging patient base worldwide and rising demand of assisted and home healthcare technologies, the point of care diagnostic market is expected to show lucrative growth over the forecast period 2016 - 2022.

Point-Of-Care Diagnostics or Testing Market

For the purpose of this study, the global point-of-care diagnostics or testing (POCT) market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Point-Of-Care Diagnostics or Testing Market

In base year 2015, North America accounted for the largest share in the global POCT market, followed by Asia-Pacific, Europe, and the RoW (Rest of the World). The Asia-Pacific region (comprising Japan, China and India as major countries) is anticipated to grow at the fastest CAGR during the forecast period 2016 - 2022. The key factors assisting the growth of point-of-care diagnostics market in Asia-Pacific region are the huge patient population base, large number of R&D activities carried out in diagnostics field, rising focus of both international and domestic players on the Asia-Pacific POCT market, and increasing funding/investment towards the development of Point-Of-Care Diagnostics / Testing products.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients